Arrowstreet Capital
LEGN icon

Arrowstreet Capital’s Legend Biotech LEGN Stock Holding History

Arrowstreet Capital’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.36M Buy
406,901
+315,176
+344% +$6.01M ﹤0.01% 1032
2025
Q4 		$1.99M Buy
+91,725
New +$2.63M ﹤0.01% 1411
2024
Q2 		– Sell
-4,827
Closed -$271K – 1661
2024
Q1 		$271K Buy
+4,827
New +$291K ﹤0.01% 1540
2023
Q1 		– Sell
-5,903
Closed -$295K – 1440
2022
Q4 		$295K Sell
5,903
-140,184
-96% -$6.79M ﹤0.01% 1206
2022
Q3 		$5.96M Buy
+146,087
New +$6.86M 0.01% 619
2022
Q2 		– Sell
-48,365
Closed -$1.76M – 1337
2022
Q1 		$1.76M Buy
+48,365
New +$1.91M ﹤0.01% 832
2021
Q1 		– Sell
-8,279
Closed -$233K – 2390
2020
Q4 		$233K Buy
+8,279
New +$238K ﹤0.01% 2169

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Arrowstreet Capital's LEGN Position: Q1 2026 in Review

Arrowstreet Capital increased its Legend Biotech (LEGN) stake by 344% in Q1 2026, buying an estimated $6.01M and bringing the position to 406,901 shares worth $7.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1032.

Arrowstreet Capital first reported a position in LEGN in Q4 2020 and has held it in 7 quarters since. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Arrowstreet Capital held 406,901 shares of Legend Biotech worth $7.36M as of Q1 2026.
  • Arrowstreet Capital bought 315,176 Legend Biotech shares in Q1 2026, an estimated $6.01M.
  • Legend Biotech made up ﹤0.01% of Arrowstreet Capital's portfolio in Q1 2026, its #1032 holding.
  • Arrowstreet Capital first reported a position in Legend Biotech in Q4 2020 and has held it in 7 quarters since.
  • 190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.